Below is the United Kingdom government response to the European Commission’s concept paper on the introduction of fees to be charged by the European Medicines Agency for pharmacovigilance.

 

UK government response to the European Medicines Agency (EMA) pharmacovigilance fees consultationPDF file (opens in new window)

 

Posted on the UK MHRA website on 19 Sep 2012